*1.Please list your first name, last name, and email:(Required.)

First name:

Last name:

Email:

*2.What is your specialty?(Required.)

*3.How many patients with pancreatic cancer do you treat each week?(Required.)

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

*4.The presence of KRAS G12R mutation is associated with unique metabolic features and higher dependency on autophagy.(Required.)

True

False

*5.Inhibition of the MAPK pathway leads to autophagic flux in pancreatic cancer cells.(Required.)

True

False

*6.Combined MAP kinase and autophagy inhibition can be a potential treatment option for pancreatic cancer.(Required.)

True

False